Bosh sahifaPEN • NYSE
add
Penumbra Inc
335,85 $
Seans yopilganidan keyin:(0,00%)0,00
335,85 $
Yopilgan:20-mar, 16:56:01 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
337,35 $
Kunlik diapazon
335,79 $ - 337,94 $
Yillik diapazon
221,26 $ - 362,41 $
Bozor kapitalizatsiyasi
13,18 mlrd USD
Oʻrtacha hajm
681,16 ming
Narx/foyda
74,27
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 385,38 mln | 22,14% |
Joriy xarajat | 202,90 mln | 20,81% |
Sof foyda | 47,34 mln | 40,55% |
Sof foyda marjasi | 12,28 | 14,98% |
Har bir ulushga tushum | 1,18 | 21,65% |
EBITDA | 63,49 mln | 39,16% |
Amaldagi soliq stavkasi | 25,60% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 544,82 mln | 60,18% |
Jami aktivlari | 1,83 mlrd | 19,13% |
Jami passivlari | 398,92 mln | 4,36% |
Umumiy kapital | 1,43 mlrd | — |
Tarqatilgan aksiyalar | 39,24 mln | — |
Narxi/balansdagi bahosi | 9,27 | — |
Aktivlardan daromad | 8,29% | — |
Kapitaldan daromad | 9,19% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 47,34 mln | 40,55% |
Operatsiyalardan naqd pul | 86,48 mln | 69,22% |
Sarmoyadan naqd pul | -225,65 mln | -1 959,76% |
Moliyadan naqd pul | 5,06 mln | -16,66% |
Naqd pulning sof oʻzgarishi | -134,13 mln | -405,35% |
Boʻsh pul | 50,26 mln | 55,13% |
Haqida
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend. Wikipedia
Tashkil etilgan
2004
Sayt
Xodimlar soni
4 700
